USP Pyrroloquinoline quinone disodium salt，PQQ， CAS NO. 122628-50-6 CAS NO.122628-50-6

1)Professional team-Management and professional technical team
2)Good quality:Provide high quality products
3)OEM&ODM-OEM and ODM generation processing are warmly welcomed
4)After sale-Sincerely servesevery customer with 24 hours.
5)Delivery Time:7 day

Pyrroloquinoline Quinone Disodium(PQQ)

Chemical Name: disodium4,5-dihydro-4,5-dioxo-1h-pyrrolo(2,3-f)quinoline-2,7,9-tricarboxylat

Color：Reddish-brown powder

Appearance：Oderless

Melting Point：>300℃

Solubility: soluble in water, insoluble in ethanol

Storage: room temperature

SYNTAME is a national level technology oriented enterprise that focuses on the R&D, production and sales of API and pharma-intermediates. It is committed to process R&D of original pharma-intermediates, as well as optimizing and controlling costs in the process of generic pharma-intermediates. It provides various pharmaceutical related products and technical solutions for the domestic and foreign pharmaceutical markets.

SYNTAME focuses on the API and pharma-intermediates of cardiovascular, diabetes and antipsychotic drugs which mainly apply to Apixaban, Ezetimibe, Gliquidone, Pazopanib, etc. The core R&D team has more than 15 years of experience in drug R&D and production. It has fixed production bases in Anhui and Henan province, with a production capacity of thousands of tons. It can produce special reactions such as Hydrogenation & Nitrification, and undertake CMO of high-end pharma-intermediates. Products are exported to international and domestic markets such as Europe, United States, and Southeast Asia, etc.

SYNTAME adheres to the management philosophy of "Quality first, Technological Innovation", strengthens optimization management and technological innovation, and has passed the ISO9001:2015 Quality Management System; ISO14001:2015 Environmental Management System; ISO45001:2018 Occupational Health and Safety Management System, strengthening management and skill training. The company has an independent R&D system, and currently has 3 invention patents and 3 invention patent applications, adhering to technological innovation.

Based on the market and closely following the development of the pharmaceutical industry, we sincerely invite domestic and foreign customers to develop together and achieve a win-win situation, striving for human health.